Lucija Peterlin Mašič

发表

5‐Benzylidenethiazolidin‐4‐ones as Multitarget Inhibitors of Bacterial Mur Ligases

S. Turk, S. Grdadolnik, M. Filipič, 2010, ChemMedChem.

Discovery of novel 5-benzylidenerhodanine and 5-benzylidenethiazolidine-2,4-dione inhibitors of MurD ligase.

S. Turk, D. Patin, D. Blanot, 2010, Journal of medicinal chemistry.

Rhodanine as a scaffold in drug discovery: a critical review of its biological activities and mechanisms of target modulation

T. Tomašič, Lucija Peterlin Mašič, 2012, Expert opinion on drug discovery.

A New Cell‐Based AI‐2‐Mediated Quorum Sensing Interference Assay in Screening of LsrK‐Targeted Inhibitors

J. Ilaš, M. Anderluh, T. Tomašič, 2020, Chembiochem : a European journal of chemical biology.

Data on biosynthesis of BPAF glucuronide, enzyme kinetics of BPAF glucuronidation, and molecular modeling

M. Finel, T. Tomašič, A. Zega, 2018, Data in brief.

Antimicrobial Activity of the Marine Alkaloids, Clathrodin and Oroidin, and Their Synthetic Analogues

Danijel Kikelj, Päivi Tammela, J. Ilaš, 2014, Marine drugs.

N-Phenyl-4,5-dibromopyrrolamides and N-Phenylindolamides as ATP Competitive DNA Gyrase B Inhibitors: Design, Synthesis, and Evaluation.

J. Ilaš, T. Šolmajer, T. Tomašič, 2015, Journal of medicinal chemistry.

Inhibition of biofilm formation by conformationally constrained indole-based analogues of the marine alkaloid oroidin.

G. Węgrzyn, J. Ilaš, M. Łoś, 2014, Bioorganic & medicinal chemistry letters.

Efflux pump inhibitors of clinically relevant multidrug resistant bacteria

T. Tomašič, D. Kikelj, Lucija Peterlin Mašič, 2019, Medicinal research reviews.

The effects of bisphenols on the cardiovascular system

M. Dolenc, P. Mladěnka, Lucija Peterlin Mašič, 2022, Critical reviews in toxicology.

Evaluation of endocrine activities of ellagic acid and urolithins using reporter gene assays.

T. Tomašič, A. Zega, Lucija Peterlin Mašič, 2019, Chemosphere.

New N-phenyl-4,5-dibromopyrrolamides as DNA gyrase B inhibitors.

J. Ilaš, T. Tomašič, Nace Zidar, 2019, MedChemComm.

Bioactivation potential of thiophene-containing drugs.

Lucija Peterlin Mašič, M. Sollner Dolenc, Darja Gramec, 2014, Chemical research in toxicology.

Identification of Novel Chemical Scaffolds Inhibiting Trypanothione Synthetase from Pathogenic Trypanosomatids

C. Kunick, L. Flohé, A. Detsi, 2016, PLoS neglected tropical diseases.

Discovery of 4,5,6,7-Tetrahydrobenzo[1,2-d]thiazoles as Novel DNA Gyrase Inhibitors Targeting the ATP-Binding Site.

J. Ilaš, M. Anderluh, T. Šolmajer, 2015, Journal of medicinal chemistry.

Discovery of new ATP-competitive inhibitors of human DNA topoisomerase IIα through screening of bacterial topoisomerase inhibitors.

Ž. Skok, J. Ilaš, T. Tomašič, 2020, Bioorganic chemistry.

Discovery of Benzothiazole Scaffold-Based DNA Gyrase B Inhibitors.

J. Ilaš, T. Tomašič, D. Kikelj, 2016, Journal of medicinal chemistry.

Dual Escherichia coli DNA Gyrase A and B Inhibitors with Antibacterial Activity

C. Pál, Ž. Skok, J. Ilaš, 2019, ChemMedChem.

Bisphenol A and its analogs: Do their metabolites have endocrine activity?

Lucija Peterlin Mašič, Darja Gramec Skledar, 2016, Environmental toxicology and pharmacology.

Analogues of the Lignan Pinoresinol as Novel Lead Compounds for P-glycoprotein (P-gp) Inhibitors.

T. Tomašič, D. Kikelj, Lucija Peterlin Mašič, 2018, ACS medicinal chemistry letters.

New Diarylamine KV10.1 Inhibitors and Their Anticancer Potential

L. Pardo, J. Tytgat, S. Peigneur, 2022, Pharmaceutics.

Applicability of the OECD 455 in-vitro assay for determination of hERa agonistic activity of isoflavonoids.

P. Horký, P. Mladěnka, A. Zega, 2019, Toxicology and applied pharmacology.

New brominated flame retardants and their metabolites as activators of the pregnane X receptor.

E. Distrutti, S. Fiorucci, T. Tomašič, 2016, Toxicology letters.

Bazedoxifene-scaffold-based mimetics of solomonsterols A and B as novel pregnane X receptor antagonists.

S. Fiorucci, T. Tomašič, D. Kikelj, 2014, Journal of medicinal chemistry.

New N-phenylpyrrolamide DNA gyrase B inhibitors: Optimization of efficacy and antibacterial activity.

C. Pál, Ž. Skok, J. Ilaš, 2018, European journal of medicinal chemistry.

Physiologically Based Pharmacokinetic (PBPK) Modeling of the Bisphenols BPA, BPS, BPF, and BPAF with New Experimental Metabolic Parameters: Comparing the Pharmacokinetic Behavior of BPA with Its Substitutes

Konrad Hungerbühler, Natalie von Goetz, Thomas Roiss, 2018, Environmental health perspectives.

Investigation of the Influence of CYP1A2 and CYP2C19 Genetic Polymorphism on 2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-butenamide (A77 1726) Pharmacokinetics in Leflunomide-Treated Patients with Rheumatoid Arthritis

A. Mrhar, M. Tomšič, Lucija Peterlin Mašič, 2009, Drug Metabolism and Disposition.

Mutagenicity and DNA Damage of Bisphenol a and its Structural Analogues in Hepg2 Cells

M. Filipič, Lucija Peterlin Mašič, A. Fic, 2013, Arhiv za higijenu rada i toksikologiju.

Novel 2-thioxothiazolidin-4-one inhibitors of bacterial MurD ligase targeting D-Glu- and diphosphate-binding sites.

S. Grdadolnik, D. Blanot, Andreja Kovač, 2011, European journal of medicinal chemistry.

Estrogenic potency of endocrine disrupting chemicals and their mixtures detected in environmental waters and wastewaters.

R. Roškar, Lucija Peterlin Mašič, J. Trontelj, 2023, Chemosphere.

Differences in the glucuronidation of bisphenols F and S between two homologous human UGT enzymes, 1A9 and 1A10

M. Finel, Lucija Peterlin Mašič, Johanna Troberg, 2015, Xenobiotica; the fate of foreign compounds in biological systems.

New Dual Inhibitors of Bacterial Topoisomerases with Broad-Spectrum Antibacterial Activity and In Vivo Efficacy against Vancomycin-Intermediate Staphylococcus aureus

Guido V. Janssen, C. Pál, L. Pardo, 2023, Journal of medicinal chemistry.

Discovery and Hit-to-Lead Optimization of Benzothiazole Scaffold-Based DNA Gyrase Inhibitors with Potent Activity against Acinetobacter baumannii and Pseudomonas aeruginosa

Guido V. Janssen, B. Birnir, C. Stevenson, 2023, Journal of medicinal chemistry.

Immunosuppressive effects of new thiophene-based KV1.3 inhibitors.

L. Pardo, J. Tytgat, A. Becchetti, 2023, European journal of medicinal chemistry.

A. Mrhar, M. Tomšič, Lucija Peterlin Mašič, 2009, Drug Metabolism and Disposition.

ATP-competitive inhibitors of human DNA topoisomerase IIα with improved antiproliferative activity based on N-phenylpyrrolamide scaffold.

Ž. Skok, J. Ilaš, T. Tomašič, 2023, European journal of medicinal chemistry.

Molecular Dynamics-Derived Pharmacophore Model Explaining the Nonselective Aspect of KV10.1 Pore Blockers

L. Pardo, F. Merzel, T. Tomašič, 2021, International journal of molecular sciences.

Bazedoxifene-scaffold-based mimetics of solomonsterols A and B as novel pregnane X receptor antagonists.

S. Fiorucci, T. Tomašič, D. Kikelj, 2014, Journal of medicinal chemistry.